Clinical trial
Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage…
NCT00093665 · Aichi Cancer Center, Other · Unknown status
Key facts
| NCT number | NCT00093665 |
|---|---|
| Title | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer |
| Official title | A Phase II Study Of Alternating Chemoradiotherapy For Nasopharyngeal Cancer Using Cisplatin And 5-Fluorouracil |
| Lead sponsor | Aichi Cancer Center, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | cisplatin, fluorouracil, radiation therapy |
| Enrollment | 90 |
| Start date | Nov 1, 2003 |
| First posted | Oct 8, 2004 |
| Last update posted | May 15, 2013 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: